Cancer

RSS

French institutes join forces to design pseudopeptide MMP inhibitors

Sep. 12, 2000

Antiproliferative Ca2+ channel blockers and SAR reported by U. Virginia

Sep. 12, 2000

New taxoid RPR-109881A evaluated in phase I trial in patients with solid tumors

Sep. 12, 2000

Yamanouchi discovers naturally occurring cytotoxic depsipeptide

Sep. 8, 2000

Pharmacia's Aromasin receives clearance from Health Canada

Sep. 7, 2000

Bayer investigates inhibition of raf kinase signaling pathway as new approach to cancer

Sep. 6, 2000

New antitumor compound from Banyu produced by microorganism

Sep. 5, 2000

MEK inhibitors and their use described in recent patents

Sep. 5, 2000

PARP inhibitors reportedly useful in combination with cytotoxic agents

Sep. 5, 2000

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000